General Information of Drug Combination (ID: DCB8VR3)

Drug Combination Name
BIO-300 Vinflunine
Indication
Disease Entry Status REF
Carcinoma Investigative [1]
Component Drugs BIO-300   DMJ7NVI Vinflunine   DMTJAEP
N.A. Small molecular drug
High-throughput Screening Result Testing Cell Line: MCF7
Zero Interaction Potency (ZIP) Score: 6.26
Bliss Independence Score: 6.67
Loewe Additivity Score: 8.49
LHighest Single Agent (HSA) Score: 10.57

Test Results of This Drug Combination in Other Disease Systems

Indication DrugCom ID Cell Line Status REF
Anaplastic large cell lymphoma DCINVKA SR Investigative [5]
Astrocytoma DCW4QSJ SNB-19 Investigative [5]
Childhood T acute lymphoblastic leukemia DC1DGTQ CCRF-CEM Investigative [5]
Chronic myelogenous leukemia DCZGARG K-562 Investigative [5]
Glioblastoma DCM5X09 SNB-75 Investigative [5]
Glioma DCE2RTA SF-295 Investigative [5]
Glioma DCS57CK SF-539 Investigative [5]
Adenocarcinoma DCAJO7H HCT-15 Investigative [6]
High grade ovarian serous adenocarcinoma DCFPX4H OVCAR-8 Investigative [6]
Mixed endometrioid and clear cell carcinoma DC4W9SH IGROV1 Investigative [6]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 DrugCom(s)

References

1 CheMBL Affinity Phenotypic Cellular Interaction Assay ID: CHEMBL1126165
2 Clinical pipeline report, company report or official report of Humanetics.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
5 CheMBL Affinity Phenotypic Cellular Interaction Assay ID: CHEMBL1125966
6 CheMBL Affinity Phenotypic Cellular Interaction Assay ID: CHEMBL1125976